AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Colorectal Cancer Patients Participate In Clinical Trial.(Brief Article)
2001 NOV 14 - (NewsRx.com & NewsRx.net) -- An investigational vaccine for the treatment of colorectal cancer, one of the most common and deadly forms of cancer, has been cleared by the U.S. Food and Drug Administration (FDA) for clinical trial.
Alvac, developed by Aventis Pasteur, the vaccine arm of Aventis Pharma, will be studied in combination with standard chemotherapy. The multicenter U.S. trial is expected to begin enrolling patients in the fall of 2001.
The colorectal trial will test the safety and immunogenicity of the Alvac-based vaccine. The study will examine the safety of the vaccine when administered with chemotherapy and will determine how the immune response to the vaccine is affected by chemotherapy that is typically offered to patients with recurrent colorectal cancer. The study is being conducted at major cancer centers across the United States and is expected to last approximately one year.
"We are very pleased to have received clearance from the FDA to test the safety and efficacy of Alvac in treating colorectal cancer," said Dr. Neil Berinstein, Aventis Pasteur. "The goal is to see if the vaccine, combined with chemotherapy, ...
- Therion Biologics and Aventis Pasteur Expand Cancer Vaccine Alliance --Clinical...
- News wire article from: Canadian Corporate News October 27, 2000 700+ words
...treatment of colorectal cancer. Based on...results, Aventis Pasteur plans to...to treat colorectal cancer, lung cancer...melanoma. Aventis Pasteur also acquires...Therion and Aventis Pasteur over the...advance our colorectal cancer product ...
- Aventis Pasteur Acquires Exclusive Rights to Develop Novel Cancer Targets...
- Press release article from: PR Newswire January 13, 2003 700+ words
...Aventis Pasteur: Aventis Pasteur SA is the largest...vaccines. In 2001, Aventis Pasteur produced 1.3 billion...in Lyon, France, Aventis Pasteur is owned by Aventis...development are for colorectal cancer and melanoma, and...
- A New Weapon in the Battle Against Cancer; Aventis Pasteur opts for Ontario as...
- Press release article from: PR Newswire January 13, 2004 700+ words
...of the deadliest diseases. Aventis Pasteur, a world leader in vaccine...Two cancer vaccines, for colorectal cancer and melanoma, are currently...also begun in breast cancer. Aventis Pasteur's goal is to generate a series...
- AVENTIS PICKS FIVE EOS TARGETS; VACCINE DEAL ENDS WITH 'BANG'.(Aventis Pasteur,...
- Magazine article from: BIOWORLD Today Osborne, Randall January 14, 2003 700+ words
...Two years after starting their deal for cancer vaccines, Aventis Pasteur has exercised its option to develop up to five targets...and viral diseases, with two in clinical development for colorectal cancer and melanoma - the deal signed in June 2000 works out well...
- Colorectal Cancer Patients Participate In Clinical Trial.(Brief Article)
- Newspaper article from: Immunotherapy Weekly November 14, 2001 700+ words
...treatment of colorectal cancer, one of the...developed by Aventis Pasteur, the vaccine...in treating colorectal cancer," said Dr...Berinstein, Aventis Pasteur. "The goal...United States, colorectal cancer accounts for...
- Colorectal Cancer Patients Participate In Clinical Trial.
- Newspaper article from: Gene Therapy Weekly November 15, 2001 700+ words
...treatment of colorectal cancer, one of the...developed by Aventis Pasteur, the vaccine...in treating colorectal cancer," said Dr...Berinstein, Aventis Pasteur. "The goal...United States, colorectal cancer accounts for...
- Novel Colorectal Cancer Trial Seeking Patient Volunteers At Leading U.S. Cancer...
- Press release article from: PR Newswire February 11, 2002 700+ words
...strategy for colorectal cancer using a therapeutic...metastatic colorectal cancer not yet treated...according to Aventis Pasteur Limited of...metastatic colorectal cancer with the standard...Cancer, Aventis Pasteur. "We will...
- Clinical Trial For Innovative Colorectal Cancer Vaccine Scheduled to Commence.
- Press release article from: PR Newswire October 1, 2001 700+ words
...studied to treat colorectal cancer, one of the...developed by Aventis Pasteur, the vaccine...recurrent colorectal cancer. The study...in treating colorectal cancer," said Dr...cancer, at Aventis Pasteur. "The goal...